Dan Lapinski

Dan represents victims of childhood sexual abuse who seek to hold abusers and abuse enablers accountable in civil court under “window” laws. Newly enacted in many states and pending in others, these laws extend the number of years available for victims to file a childhood sexual abuse claim by opening a statute of limitations window for a finite period of time. Dan also represents former Boy Scouts who suffered abuse with claims against the Boy Scouts of America bankruptcy.

As a mass tort attorney, Dan represents victims harmed by dangerous pharmaceutical products and defective medical devices. His perspective and approach to litigation is shaped by his previous experience as a surgical representative for a major medical device manufacturer.  

Dan plays an active role in numerous mass tort cases, including as a member of the Plaintiffs’ Steering Committees for the following multidistrict litigations, among others:

  • In re Proton-Pump Inhibitor Prods. Liability Litigation (No. II), D.N.J.
  • In re Johnson & Johnson Talcum Powder Products Liability Litigation, D.N.J. 

Additionally, Dan has successfully argued preemption issues before federal appellate courts, and has represented clients in class actions regarding shareholder derivatives, alleged deceptive marketing of vehicles and pharmaceutical products, and alleged negligence contributing to a massive apartment fire, in cases including:

  • DeMarco v. AvalonBay Communities, Inc., D.N.J.
  • D.C.G. & T., et al., v. Knight, et al., E.D. Va.
  • In re Ford Explorer Cases, (Cal. Sacramento Cnty. Super. Ct.) 
  • Alexander v. Solvay Pharmaceuticals, Inc., (Cal. Los Angeles Cnty. Super. Ct. 
  • Slaughter v. Unilever United States, Inc., D.N.J.

Prior to joining Motley Rice, Dan served among the leadership of the mass tort and class action team of a New Jersey law firm.

Dan is a frequent speaker on the local and national levels regarding mass tort and class action litigations, including presenting at the New Jersey State Bar annual conference, and serving as a panelist for both Harris Martin Publishing and the American Association of Justice. He has also been a regular speaker at New Jersey Association for Justice’s Annual Boardwalk Seminar. 


Motley Rice LLC, a South Carolina Limited Liability Company, is engaged in the New Jersey practice of law through Motley Rice New Jersey LLC. Esther Berezofsky attorney responsible for New Jersey practice.

LITIGATION AREAS

Consumer Fraud ProtectionHuman RightsMedical DevicesMedical DrugsPersonal Injury and Wrongful Death

EDUCATION

J.D., Seton Hall University School of Law, 1999

B.A., Rutgers University, 1990

LICENSED IN

  • New Jersey
  • New York
  • Pennsylvania

ADMITTED TO PRACTICE BEFORE

U.S. Supreme Court

U.S. Court of Appeals for the First, Third, Fourth, Sixth and Tenth Circuits

Supreme Court of New Jersey

Supreme Court of New York, First Judicial Department

Supreme Court of Pennsylvania, Western District

U.S. District Court for the Eastern and Middle Districts of Pennsylvania, District of New Jersey, and Eastern and Southern Districts of New York

ASSOCIATIONS

American Association for Justice

New Jersey Association for Justice

New Jersey State Bar Association

Awards and Accolades

Super Lawyers®

2013–2022  New Jersey Super Lawyers list
2011  New Jersey Super Lawyers Rising Stars list
No aspect of this advertisement has been approved by the Supreme Court of New Jersey.

Lawdragon

2022 Lawdragon 500 Plaintiff Consumer Lawyers

Casework

Boy Scouts Sexual Abuse Claim

For decades, millions of families have trusted the Boy Scouts of America to lead and nurture their sons, but for an untold number of boys, that trust was met with betrayal in the form of sexual abuse by scout leaders. Survivors and their families are coming forward.

Human Rights

Elmiron Vision Loss Lawsuit

People taking Elmiron, seeking relief from the pain and discomfort caused by IC, have reported experiencing unexpected complications, including a newly discovered, progressive eye disease that may result in permanent vision loss.

Medical Drugs

 

© 2022 Epiq. All rights reserved.